Skip to main content
. Author manuscript; available in PMC: 2022 Sep 22.
Published in final edited form as: Vaccine. 2020 Aug 2;38(38):6027–6037. doi: 10.1016/j.vaccine.2020.06.074

Table 4:

Added contribution of barriers after adjusting for HPV vaccine hesitancy (n=2020)

Practical Barriers Received ≥1 HPV Vaccine (aRR, 95% CI) Completed HPV Vaccine Series (aRR, 95% CI) Refused HPV Vaccine Because of Concerns About the Vaccine (aRR, 95% CI)
It was/would be convenient to get the HPV vaccine for my adolescent [Disagree]. 0.58 (0.48, 0.71) 0.48 (0.36, 0.64) 1.16 (1.04, 1.28)
My adolescent’s provider recommended that my adolescent get the HPV vaccine [Disagree]. 0.29 (0.23, 0.37) 0.33 (0.25, 0.43) 0.98 (0.88, 1.09)
Paying for the HPV vaccine was/would be hard for me. [Agree] 0.91 (0.83, 1.00) 0.91 (0.79, 1.05) 0.90 (0.79, 1.03)
I did not/would not have a way to get to a place where my adolescent could get the HPV vaccine [Agree]. 0.89 (0.75, 1.04) 0.97 (0.78, 1.21) 0.86 (0.70, 1.06)
I do not have a regular source of medical care for my adolescent [Agree]. 0.83 (0.73, 0.95) 0.81 (0.66, 0.98) 1.00 (0.87, 1.15)
My adolescent’s provider did not have the vaccine available during their most recent visit [Agree]. 0.82 (0.70, 0.96) 0.73 (0.56, 0.94) 1.12 (0.96, 1.30)
*

aRRs adjusted for only HPV vaccine hesitancy